HYB0:F:F-HOYA CORP. ADR/ 1 O.N. (EUR)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 120

Change

-2.00 (-1.64)%

Market Cap

USD 42.88B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it engages in the research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. Additionally, the company offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke, a time and attendance management service, as well as Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
IUI1:F Intuitive Surgical Inc

-2.05 (-0.47%)

USD 158.73B
ESLC:F ESSILORLUXOTTICA 1/2/O.N.

-3.00 (-2.88%)

USD 95.76B
ESL:F EssilorLuxottica Société ano..

-0.30 (-0.15%)

USD 95.72B
BOX:F Becton Dickinson and Company

-3.00 (-1.43%)

USD 61.57B
HYB:F HOYA Corporation

-1.65 (-1.33%)

USD 42.41B
RME:F ResMed Inc

-14.90 (-6.56%)

USD 33.80B
RMEA:F Resmed Inc DRC

-0.60 (-2.68%)

USD 33.02B
CBH:F COLOPLAST SP.ADR 1/10 DK1

-0.20 (-1.61%)

USD 27.61B
CBHD:F Coloplast A/S

-4.50 (-3.56%)

USD 27.31B
QS50:F STRAUM.HLD.UNSP.ADR/1/10

N/A

USD 20.01B

ETFs Containing HYB0:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.09% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.09% 55% F 56% F
Trailing 12 Months  
Capital Gain 22.45% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.45% 65% D 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.98% 65% D 58% F
Dividend Return 4.98% 54% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.60% 95% A 91% A-
Risk Adjusted Return 57.88% 81% B- 75% C
Market Capitalization 42.88B 96% N/A 95% A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.